Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning
Omar, H.; Kives, S.
Journal of Pediatric and Adolescent Gynecology 18(3): 183
2005
ISSN/ISBN: 1083-3188 PMID: 15970252 DOI: 10.1016/j.jpag.2005.03.007Document Number: 255494
Document emailed within 0-6 h
Related Documents
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Kaunitz, A.M.; Grimes, D.A. 2011: Removing the black box warning for depot medroxyprogesterone acetate Contraception 84(3): 212-213
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Cromer, B.A.; Smith, R.D.; Blair, J.M.; Dwyer, J.; Brown, R.T. 1994: A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception Pediatrics 94(5): 687-694
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Bahemuka, M. 1981: Benign intracranial hypertension associated with the use of depo-provera (depot medroxyprogesterone): a case report East African Medical Journal 58(2): 140-141
Soichet, S. 1969: Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent International Journal of Fertility 14(1): 33-38
Ozgoli, G.; Sheikhan, Z.; Dolatian, M.; Simbar, M.; Bakhtyari, M.; Nasiri, M. 2015: Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem Journal of Reproduction and Infertility 16(2): 102-108
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Chaudhri, R.; Rizvi, F.; Afzal, M. 2010: Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as contraceptive Jpma. Journal of the Pakistan Medical Association 60(7): 536-540